Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Imaflex Inc.
  6. News
  7. Summary
    IFX   CA4524352099

IMAFLEX INC.

(IFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Imaflex Inc. Updates on Its ADVASEAL Study

11/25/2020 | 07:30am EST

Imaflex Inc. is conducting a Release Study, which is the last and most comprehensive trial required prior to submitting the U.S. Environmental Protection Agency (EPA) registration package. The study determines the exact timing for release of each active ingredient (herbicide, nematicide and fungicides) coated on the new ADVASEAL®. This is required to show compliance with the pre-harvest interval legally established by the EPA, which is essentially the wait time required between the application of crop protection products onto the soil and when a crop can be harvested for safe human consumption. Imaflex will announce the independent trial results once available. The Corporation remains focused on submitting the registration package with the EPA around year-end 2020. Once submitted, the EPA review process can take up to a year to complete.


ę S&P Capital IQ 2020
All news about IMAFLEX INC.
11/24Imaflex Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septe..
CI
11/24Imaflex Announces Top and Bottom Line Growth for Q3 2021 and Provides Business Update
AQ
08/25Imaflex Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/25IMAFLEX : Announces Strong Q2 2021 Results and Provides Business Update
AQ
06/17IMAFLEX : Announces Results of Annual General Meeting of Shareholders
AQ
05/26IMAFLEX : Reports Strong Q1 2021 Results and Provides Business Update
AQ
04/15IMAFLEX : Reports Strong Q4 and FY 2020 Results and Provides Business Update
AQ
01/25IMAFLEX : Announces Positive Independent Results for the ADVASEAL« Release Study
AQ
01/25Imaflex Announces Positive Independent Results for the ADVASEAL Release Study
CI
2020Imaflex Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
More news
Financials
Sales 2021 108 M 84,5 M 84,5 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 64,5 M 50,4 M 50,4 M
Capi. / Sales 2021 0,60x
Capi. / Sales 2022 0,63x
Nbr of Employees 218
Free-Float 54,2%
Chart IMAFLEX INC.
Duration : Period :
Imaflex Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 1,25 CAD
Average target price 1,75 CAD
Spread / Average Target 40,0%
Managers and Directors
Joseph Abbandonato Chairman, President & Chief Executive Officer
Giancarlo Santella Chief Financial Officer
Gerald R. Phelps Vice President-Operations
Michel Baril Independent Director
Philip Nolan Independent Director
Sector and Competitors
1st jan.Capi. (M$)
IMAFLEX INC.20.19%50
BERRY GLOBAL GROUP, INC.22.92%9 497
APTARGROUP, INC.-12.59%7 820
FP CORPORATION-7.84%2 855
SCIENTEX BERHAD6.94%1 657
EASTERN POLYMER GROUP PUBLIC COMPANY LIMITED57.75%925